SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter visit http://www.smallcapreview.com/.
Aeterna Zentaris (Nasdaq: AEZS) $1.24. Today announced that it has received from the
Juergen Engel, Ph. D., President and CEO of Aeterna Zentaris stated, "We are very pleased with AEZS-108 gaining orphan-drug designation for ovarian cancer from the FDA as it would provide it with extra market exclusivity protection. We look forward to reporting the final results from our ongoing European Phase 2 study in ovarian and endometrial cancer, later this year."
What They Do: Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy.
Gulfport Energy Corporation (Nasdaq: GPOR) $12.16. Today announced financial and operating results for the first quarter of 2010. For the first quarter of 2010, Gulfport reported net income of $10.0 million on oil and gas revenues of $27.3 million, or $0.23 per diluted share. EBITDA (as defined below) for the first quarter of 2010 was $18.8 million and cash flow from operating activities before changes in working capital (as defined below) was $18.0 million.
For the first quarter of 2010, net production was 415,644 barrels of oil, 84,517 thousand cubic feet ("MCF") of natural gas and 608,093 gallons of natural gas liquids ("NGL"), or 444,209 BOE. Net production for the first quarter of 2010 by region was 386,334 BOE in Southern Louisiana, 49,144 BOE in the Permian Basin and 8,731 BOE in the Bakken.
What They Do: Gulfport Energy Corporation is an Oklahoma City-based independent oil and natural gas exploration and production company with its principal producing properties located along the Louisiana Gulf Coast and the Permian Basin in West Texas.
Questcor Pharmaceuticals (Nassdaq: QCOR) $9.16. Today announced that
What They Do: Questcor Pharmaceuticals, Inc. is a pharmaceutical company that markets H.P. Acthar Gel (repository corticotropin injection).
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview.